Daily Stock List
Magnolia Solar Corp. (MGLT)
IRGnews Alert and SmallCapStockPlays reported recently on Magnolia Solar Corp. (MGLT), PennyStockRumors.net and Actual Gains did earlier, and we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Magnolia Solar Corp. was founded in 2008 to develop and commercialize innovative new thin film solar cell technologies that employ nanostructured materials and designs. Both higher current and voltage outputs are expected from thin film solar cells that combine the Company's exclusive material structures with advanced optical coatings. Magnolia Solar is based in Woburn, Massachusetts and Albany, New York. Their relationship with Albany Nanotechnology Center offers their scientists and engineers with modern R&D equipment. Magnolia Solar lists on the OTC Bulletin Board.
Magnolia's patent-pending technology can capture a larger part of the solar spectrum to produce high efficiency solar cells. The technology incorporates an innovative nanostructure-based antireflection coating technology to increase the solar cell's efficiency further. Therefore, this reduces the cost per watt. The Company's technology targets electrical power generation applications, such as power for electrical grids and distributed power applications ranging from commercial and residential lighting to specialized military applications.
This past November, Magnolia Solar announced that their wholly owned subsidiary, Magnolia Solar, Inc., received a $750,000 Phase II award from the United States Air Force Research Laboratory as part of the Small Business Innovative Research (SBIR) program. The award will fund a two-year project. The Phase II award is to optimize the device and apply advanced anti-reflective coatings to build ultra-high efficiency flexible solar power solutions for defense applications.
Magnolia Solar is exploring new limits on solar cell performance. In January, the Company announced that Dr. Roger E. Welser, the Chief Technology Officer of their wholly owned subsidiary, Magnolia Solar, Inc., presented an invited paper at a SPIE Photonic West Conference on the Physics, Simulations and Photonic Engineering for Photovoltaic Devices. The presentation, entitled "Exploring the Radiative Limits of Dark Current Operation in InGaAs Quantum Well Solar Cells," was made on January 23, 2012 in San Francisco, as part of a special session on Quantum Well and Superlattice Solar Cells.
Magnolia Solar Corp. (MGLT) closed Tuesday's trading session at $0.07, even with yesterday’s close. The 52-week low/high is $0.05/$0.40.
GigOptix Inc. (GGOX)
OTC Markets Group, Stockpalooza, SmallCapVoice, and FeedBlitz reported previously on GigOptix Inc. (GGOX), and today we choose to highlight the Company, here at the QualityStocks Daily Newsletter.
Headquartered in San Jose, California, GigOptix Inc. is a leading supplier of semiconductor and optical components. These components enable high-speed information streaming and address emerging high growth opportunities in the communications, industrial, defense and avionics industries. GigOptix formed in March 2008 in order to facilitate a combination between GigOptix LLC and Lumera. Before the combination, GigOptix was a wholly owned subsidiary of Lumera, and formed to complete the merger.
The Company offers an extensive array of high performance MMIC solutions that enable next generation wireless microwave systems up to 90GHz and drivers, TIAs and TFPS optical modulators for 40G and 100G fiber-optic telecommunications and data-communications networks. GigOptix also offers a broad spectrum of digital and mixed-signal ASIC solutions and enables product lifetime extension through their GigOptix Sunset Rescue Program.
The Company created the GigOptix Sunset Rescue Program to help companies faced with ASIC or FPGA component obsolescence from their supplier. GigOptix has successfully implemented this program on many obsolete components in mission-critical applications. The creation of the Program was also to help companies faced with the obsolescence of a standard Integrated Circuit (IC) component from their supplier and desire to replace it with an equivalent custom part. In many cases, GigOptix can develop an equivalent drop-in replacement component. They will conduct technical feasibility to determine if an ASIC part can be created from the obsolete standards.
GigOptix's products can perform in various applications demanding a broad complement of data processing speeds. This is from consumer electronics, which perform at data processing speeds of 3Gb/s to 10Gb/s to sophisticated ultra-long haul submarine telecommunications systems, which require performance at speeds from 10Gb/s to 100Gb/s. The Company's merger with ChipX Inc. in December of 2009 allows them to provide their customers an extensive offering of value-added ASIC solutions. These include Standard Cell, Structured ASIC and Hybrid ASIC technology. GigOptix has unique expertise in PCI Express, USB 2.0, DDR/DDR2 and data conversion mixed-signal cores.
Last week, GigOptix announced that they will showcase their full portfolio of Telcordia qualified, production Thin Film Silicon on Polymer (TFPS™) Mach-Zehnder Modulators (MZMs) in addition to their 40G and 100G drivers at the OFC/NFOEC in Los Angeles, California beginning on March 6, 2012. At booth 1233, GigOptix will provide demonstrations and display various Bundled Solutions and products.
GigOptix Inc. (GGOX) closed Tuesday's trading session at $1.85, up 2.78%, on 16,560 volume. The 52-week low/high is $1.27/$3.53.
Centerline Holding Co. (CLNH)
HotOTC.com, CoolPennyStocks, Stock Rich, StockSpice, BloomMoney, and OTC Picks reported previously on Centerline Holding Co. (CLNH), and we are reporting on the Company, here at the QualityStocks Daily Newsletter.
Centerline Holding Co. is a publicly owned real estate financing and asset management holding company. Centerline Capital Group is a subsidiary of Centerline Holding. Centerline Capital Group provides real estate financing and asset management services, focused on affordable and conventional multifamily housing. Centerline Holding has their corporate headquarters in New York, New York. The Company's shares list on the OTC Bulletin Board.
Founded in 1972, Centerline has 227 employees in ten offices throughout the United States. The Company is a strategic partner of Island Capital. Centerline's organization is around four business units. These units are Asset Management, Mortgage Banking, Affordable Housing Equity, and Affordable Housing Debt. Centerline provides a spectrum of debt and equity financing to developers, owners, and investors. The Company's structuring is to originate, underwrite, service, manage, refinance, or sell through all phases of an asset's life cycle. Centerline is a leading sponsor of Low-Income Housing Tax Credit (LIHTC) funds.
Today, the Company has $9.3 billion of investor equity under management in more than 116 public and private real estate investment funds. Moreover, they manage $11.4 billion of loans in their mortgage-servicing portfolio on behalf of the Federal National Mortgage Association (Fannie Mae), the Federal Home Loan Mortgage Corporation (Freddie Mac), the Government National Mortgage Association (Ginnie Mae), and the Federal Housing Administration (FHA).
The Company's Asset Management Group consists of five divisions. These are Portfolio Management, Construction Risk Management, Performing Assets, Special Servicing, and REO and GP Portfolio. All divisions work together to review assets for investment, manage and mitigate risk in the investment portfolio, and maximize returns for the Company's investors.
In mid-October 2011, Centerline Holding announced that they filed an Entity Classification election with the Internal Revenue Service (IRS) to become an association taxable as a corporation. Previously, Centerline, a Delaware business trust, was treated as a pass through entity; all items of income and deductions flowed through to their investors. The change in tax status will result in the firm becoming subject to entity-level tax.
In 2011, Centerline opened the Alternative Capital Solutions area of the Company to source multifamily capital outside the agencies and FHA in order to provide more financing choices to their clients. In addition, they opened new offices in Atlanta, Boston, and Birmingham, and increased the small loan team to originate loans of $5.5 million or less.
Centerline Holding Co. (CLNH) closed Tuesday's trading session at $0.09, down 12.00%, on 121,470 volume. The 52-week low/high is $0.07/$0.23.
Spring Creek Healthcare Systems, Inc. (SCRK)
OTCtipReporter, PennyStockScholar, OTC Picks, and WallstreetsHotteststocks reported earlier on Spring Creek Healthcare Systems, Inc. (SCRK), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.
Trading on the OTCBB, Spring Creek Healthcare Systems, Inc. (formerly Spring Creek Capital Corp.) is a healthcare solutions company. They distribute innovative solutions for the medical, pharmaceutical and healthcare markets to resellers and consumers globally. The Company has experienced management with capital markets expertise and a host of consultants, directors and industry partners. Together, they execute effectively on diverse emerging opportunities focused on homeopathic and over-the-counter products and medical devices. Spring Creek Healthcare Systems has their corporate headquarters in New York, New York.
The Company actively pursues emerging opportunities through selecting young companies with cutting-edge concepts and launching these products and services by making use of a worldwide marketing distribution network to reach target markets. Spring Creek services the healthcare market via their various operating subsidiaries. These subsidiaries are able to take advantage of the distribution network of Spring Creek's primary and wholly owned subsidiary, Stratis Healthcare, Inc.
Stratis Healthcare provides distribution services and healthcare product logistics. Spring Creek's DelRX Pharmaceuticals subsidiary has a patented oral spray that delivers medicine through the mouth, through the buccal mucosa. The Company's Debride Corp. subsidiary has a topical therapy called Debride WH-1 used for the treatment of open wounds and ulcers.
This past December, Spring Creek Healthcare Systems announced the launch of their marketing effort to license their DelRX patents. Spring Creek holds exclusive rights to the unique drug delivery system that uses a patented process for administering medicine via the mouth, more specifically the inner lining of the cheek, known medically as the buccal mucosa. This oral spray process compares favorably with the leading technologies in nasal inhalation and injection, and has the advantage of being nonintrusive and convenient.
Two initial product lines are planned based on DelRx Pharmaceuticals' patented IP portfolio. The first is the buccal delivery of insulin. The second is for the treatment of osteoporosis with calcitonin or the treatment of breakout pain management with fentyl citarate.
Spring Creek Healthcare Systems, Inc. (SCRK) closed Tuesday's trading session at $0.01, even with yesterday’s close. The 52-week low/high is $0.01/$0.23.
CirTran Corp. (CIRC)
OTCPicks reported earlier on CirTran Corp. (CIRC), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Founded in 1993, CirTran Corp. provides complete product development and manufacturing services for a broad spectrum of business sectors. The Company provides services including first concept, design, engineering, prototyping, manufacturing, packaging and marketing. They also provide inventory control, distribution, shipping, warranty fulfillment and customer service. CirTran has their corporate headquarters in West Valley City, Utah.
In their U.S. operations, the Company provides a blend of high and medium size volume turnkey manufacturing services and products using various high-tech applications. These are for leading electronics original equipment manufacturers (OEMs) in the communications, networking, peripherals, gaming, law enforcement, consumer products, telecommunications, automotive, medical, and semiconductor industries.
CirTran's services comprise pre-manufacturing, manufacturing, and post-manufacturing services. The Company's objective is to offer customers the significant competitive advantages that are obtainable from manufacture outsourcing. In addition, CirTran markets an energy drink under the Playboy brand pursuant to a license agreement with Playboy Enterprises, Inc.
The Company conducts their business via their subsidiaries and divisions. These are CirTran Beverage, CirTran USA, CirTran Asia, CirTran Products, CirTran Media Group, and CirTran Online. CirTran Beverage manufactures, markets, and distributes Playboy-licensed energy drinks in accordance with an agreement the Company entered into with PlayBev, a consolidated variable interest entity, who holds the Playboy license.
Revenues from CirTran Beverages during the three months ended September 30, 2011 and 2010, amounted to 99 percent and 88 percent of total sales, respectively, and during the nine months ended September 30, 2011 and 2010, amounted to 97 percent and 79 percent of total sales, respectively.
CirTran USA engages in low-volume electronics assembly activities consisting primarily of the placement and attachment of electronic and mechanical components on printed circuit boards and flexible (bendable) cables. Through CirTran Asia, they manufacture and distribute electronics, consumer products, and general merchandise to companies selling in worldwide markets. CirTran Products pursues contract-manufacturing relationships in the U.S. consumer products markets, including licensed merchandise sold in the sports and entertainment markets.
CirTran Media provides end-to-end services to the direct response and entertainment industries. CirTran Online sells products by way of the Internet, and provides services and support to Internet retailers.
CirTran Corp. (CIRC) closed Tuesday's trading session at $0.001, even with yesterday’s close, on 895,000 volume.
Global Health Voyager, Inc. (GLHV)
Best Penny Alerts and ChartPoppers reported recently on Global Health Voyager, Inc. (GLHV), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Founded in 1999, Global Health Voyager, Inc. is a full-service, international medical tourism company. The Company is the owner of PlanetHospital. They offer technology solutions, medical tourism consulting services, and access to a global network of highly accredited facilities and providers to patients seeking healthcare, surgical, dental, and wellness procedures.
Global Health Voyager has their headquarters in Los Angeles, California. The Company formerly went by the name NT Media Corp. of California, Inc. They changed their name to Global Health Voyager, Inc. in August of 2011. Global Health Voyager, through established relationships with international providers, has already completed the groundwork to verify the accreditation and experience of the provider organizations they collaborate with as part of their business model.
The Company continues to add state-of-the-art medical facilities to their network, providing patients with a comprehensive list of institutions around the world where they can look for high quality medical care. The primary variable is the level of care followed by the cost associated with the trip and the procedure. An added benefit of medical travel is that the patient and his/her companion(s) can take advantage of luxurious accommodations for recuperation, as well as attractive opportunities for sightseeing and relaxation.
Recently, Global Health Voyager announced that they have initiated development of a Medical Tourism related smart phone application. The design of the App is to allow potential patients to select a procedure that they may need in the near future. This can range from minor cosmetic surgery to major procedures such as hip replacement. The App will then offer the patient comparisons of the average cost of the procedure domestically compared to several overseas destinations at accredited hospitals.
The patient will have the option to learn more about specific hospitals and other related accommodations. This is through rich content, such as medical specialties and videos. If the patient chooses, he or she will be assigned a case manager. This case manager will take him or her through the process of reviewing options and ultimately booking the procedure along with travel and accommodations, all through Global Health Voyager.
Global Health Voyager, Inc. (GLHV) closed Tuesday at $0.01, down 3.85%, on 260,244 volume.
Lake Shore Gold Corp. (LSG.TO)
Investor Ideas and Wall Street Reporter reported previously on Lake Shore Gold Corp. (LSG.TO), and we highlight the Company, here at the QualityStocks Daily Newsletter.
Lake Shore Gold Corp. is a mining company headquartered in Toronto, Ontario. Their goal is to become a mid-tier gold producer via the successful exploration, development, and operation of their properties in the Abitibi Greenstone belt in Northern Ontario and Quebec, beginning with their strong base in Timmins, Ontario. The Company continues to invest aggressively in exploration in the Timmins Camp and in their other properties in Northern Ontario and Quebec. They also own a large land position in Mexico. Lake Shore Gold's shares trade on the Toronto Stock Exchange.
In Timmins, they are in commercial production at the Timmins Mine, have intersected underground, and are developing along, mineralization at the adjacent Thunder Creek deposit, and are advancing an underground advanced exploration program at their Bell Creek Mine. Mine production is delivered to Lake Shore Gold's wholly owned mill (located on the Bell Creek Property east of Timmins). It has been refurbished and expanded to a current capacity of 2,000 tonnes per day and is currently undergoing expansion to a 3,000 tonne per day with completion targeted for late 2012.
Earlier this month, Lake Shore Gold announced that they entered into an agreement with Franco-Nevada Corp. through which Franco-Nevada will pay to the Company US$35 million for a 2.25 percent net smelter return (NSR) royalty on the sale of minerals from the Company's Timmins West Complex. Furthermore, Franco-Nevada will pay C$15 million to acquire 10,050,591 common shares of the Company on a private placement basis.
Last week, Lake Shore Gold announced an updated National Instrument (NI) 43-101 resource estimate for their Timmins West Mine. The Timmins West Mine includes the TI and TC deposits. The updated resource for the Timmins West Mine includes 1,122,500 ounces Au (5,826,000 tonnes grading 5.99 gpt in the Indicated category) and 791,500 ounces Au (4,272,000 tonnes at an average grade of 5.76 gpt) in the Inferred category. The new resource statement includes updated resources for the TI deposit from the previous estimates issued in September 2009, and the initial resource for the TC deposit that was first released on November 16, 2011.
Lake Shore Gold Corp. (LSG.TO) closed Tuesday's trading session at $1.50, up 0.67%, on 1,962,572 volume. The 52-week low/high is $1.27/$4.42.
Gryphon Gold Corp. (GYPH)
OTCPicks, AllPennyStocks, SmallCap Network, Vantage Wire, and Thestockwizards.net reported earlier on Gryphon Gold Corp. (GLHV), and we are reporting on the Company, here at the QualityStocks Daily Newsletter.
Gryphon Gold Corp. is a gold exploration, production and development company focusing on their Borealis project in Nevada. The Borealis property is in the Walker Lane gold belt of Western Nevada. Gryphon Gold formed as a private entity in 2003. In December of 2005, Gryphon Gold was taken public. The Company currently trades on the Toronto Stock Exchange (GGN.TO) and the Over the Counter securities market in the U.S (GYPH). Gryphon Gold has their headquarters in Carson City, Nevada.
In 1978, S. W. Ivosevic (1979), a Houston International Minerals Co. geologist (a subsidiary of Houston Oil and Minerals Corp.), discovered the Borealis gold deposit. In fact, 1.4 million ounces of measured and indicated gold resources and 1.1 million ounces of inferred gold resources have been accredited to the one-square-mile Central Borealis zone. Previous operators mined and heap leached more than 600,000 ounces from this zone during their collective 10-year tenure. There are at least five other highly prospective zones that are currently undergoing exploration that have the potential to host significant gold resources. Gryphon Gold has continued drilling on the Borealis property, in the Graben resource and in the central and western pediment areas.
Recently, Gryphon Gold provided an update on the startup process of their Borealis oxide gold heap leach operation. During the third quarter, a total of 199,674 tons of material was placed on the heap leach pad for processing. The material is estimated to contain 6,223 ounces of gold. During January 2012, 74,473 tons of material was placed on the leach pad. This is estimated to contain 2,244 ounces of gold.
During the third quarter of fiscal 2012, the Company sold loaded carbon containing 605 ounces of gold. The approximate average settlement price was $1,700 per ounce of gold. As of December 31, 2011, Gryphon Gold had cash on hand of $1.3 million. This declined to $250,000 as of February 2, 2012. Because of a new gold on carbon sale agreement, the Company anticipates to receive additional payments from the previously shipped loaded carbon and future shipments.
Last week, Gryphon Gold announced that they filed their third quarter fiscal year 2012 10-Q with the SEC and will release an overview of their third quarter performance after the close of financial markets on Thursday, February 23, 2012. They will host a conference call to discuss their results and progress in advancing the Borealis project on Friday, February 24, 2012 at 4:30 p.m. ET.
Gryphon Gold Corp.
) closed at $0.01, down 3.85%, on 260,244 volume.
GlobalWise Investments, Inc. (GWIV)
The QualityStocks Daily Newsletter would like to spotlight GlobalWise Investments, Inc. (GWIV). Today, GlobalWise Investments, Inc. closed trading at $0.94, up 2.17%, on 1,000 volume with 4 trades. The stock’s average daily volume over the past 60-day daily average volume is 24,771 with a 52-week low/high of $0.56/$2.15.
GlobalWise Investments, Inc. and its wholly owned subsidiary Intellinetics, Inc., a leading-edge technology company focused on the design, implementation and management of cloud-based Enterprise Content Management (“ECM”) systems in both the public and private sectors, today provided an overview of the company’s new management team. The diverse roster of highly experienced professionals contribute a combined total of more than 150 years in ECM industry experience.
GlobalWise Investments, Inc. (GWIV), via wholly-owned subsidiary Intellinetics, Inc., is a leading-edge technology company focused on Enterprise Content Management (ECM) solutions for the digital age. The ECM industry continues to grow rapidly as a result of unrestricted proliferation of digital content within today's business environment. Leveraging its proprietary cloud-based computing software, GlobalWise is poised to capture a significant market share of this burgeoning industry.
GlobalWise's ECM service is delivered to customers via five unique delivery models which cover the spectrum of business needs: Cloud/Saas (Software as a Service), Hardware Vendor Integrated Service, Software Vendor Integrated Service, Premise (Client-Server), Hybrid (Premise & Cloud/Saas).This diversity gives advanced security & privacy features with an on-demand structure needed for large Tier 3 and Tier 4 businesses that are currently underserved by the market.
The Intellinetics platform defines a new industry benchmark and game-changing approach by combining advanced virtualization & automated content management with an open and service-oriented architecture using web services. The company provides strategies, tactics, and technologies used to manage paper and digital assets from capture to long-term archive, without the need for manual processes conducted by a full time employee.
GlobalWise's management boasts a combined total of over 60 years in ECM leadership and industry experience. The ECM industry is expected to exceed $5.1 billion by 2013 with Gartner predicting a compound annual growth rate of 9.5%. IBM Market Insights predicts adoption of cloud computing to grow by 26% CAGR between 2010 through 2013. Leveraging management and key department heads, Intellinetics has a strong foundation from which to capture significant market share within the lucrative $149 billion Business Software & Services industry. Disclaimer
GlobalWise Investments Company Blog
GlobalWise Investments News:
GlobalWise Introduces New Management Team
GlobalWise Completes Acquisition of Intellinetics
eVero Announces a Strategic Partnership with Intellinetics
Beacon Enterprise Solutions Group, Inc. (BEAC)
The QualityStocks Daily Newsletter would like to spotlight Beacon Enterprise Solutions Group, Inc. (BEAC). Today, Beacon Enterprise Solutions Group, Inc. closed trading at $0.30, up 2.39%, on 56,320 volume with 11 trades. The stock’s average daily volume over the past 60-days is 60,361 with a 52-week low/high of $0.14/$0.68.
Beacon Enterprise Solutions Group, Inc. (BEAC) specializes in designing, implementing and managing high performance Information Technology Systems ("ITS") infrastructure solutions. Offering national, multi-national and global, turnkey ITS infrastructure solutions, the company is capable of delivery professional services to Fortune 1000 and large multi-site firms as they increasingly single source and outsource to reduce costs while optimizing critical planning, design, program, project and construction management and managed services.
Leveraging standardization, rapid mobilization and a just-in-time professional services approach, Beacon Enterprise Solutions serves as a single source for national, multi-national and global enterprise clients, including special practices focused on data centers, campuses, smart buildings, outside plant, wireless systems and other technology-based applications and projects. Clients are provided with consistent and predictable results anywhere in the world. The company's solutions allow clients to focus on their core businesses without the distraction of having employees spend valuable time on services that Beacon can provide on any continent, in any country using any language.
Headquartered in Louisville, Kentucky, with regional headquarters in Cincinnati, Ohio, Dublin, Ireland, and Prague, Czech Republic, in addition to personnel located throughout the United States and Europe, Beacon Enterprise Solutions services a diverse range of clients. For more than 30 years, the company has enabled businesses in a variety of vertical markets to dramatically reduce costs, enable global standardization, manage day-to-day technology systems moves, adds and changes, and take on major projects – all under a single national, multi-national or global agreement.
Beacon Enterprise Solutions has carefully assembled a seasoned management team and operating strategy to maximize organic growth and new business development across multiple vertical markets. More than 4,000 companies, from small businesses to Fortune 50 firms, have chosen the company's solutions. Disclaimer
Beacon Enterprise Solutions Group, Inc. Blog
Beacon Enterprise Solutions Group, Inc. News:
Beacon Enterprise Solutions Reports 36% Increase in Blended Project Funnel
Beacon Enterprise Solutions Hires Industry Sales Veteran
Beacon Enterprises Solutions Group, Inc. Announces 97% Increase in Gross Profits and 51% Increase in Net Sales for Fiscal Q1 2012
Consorteum Holdings, Inc. (CSRH)
The QualityStocks Daily Newsletter would like to spotlight Consorteum Holdings, Inc. (CSRH). Today, Consorteum Holdings, Inc. closed trading at $0.0105, up 5.00%, on 549,200 volume with 11 trades. The stock’s average daily volume over the past 60-day daily average volume is 260,275 with a 52-week low/high of $0.001/$0.0205.
Consorteum Holdings, Inc. (CSRH) utilizes the most technically advanced global solutions available today. By working with a multitude of global technologies, Consorteum is able to create customized programs for maximum results. This approach enables unparalleled flexibility when sourcing solutions, resulting in smarter, faster deployment of technologies, competitive pricing, and potential for new streams of revenue.
Through its exclusive software license with Tarsin Inc., the company leverages a team of software developers that understands the complexities of delivering digital media content across mobile handsets. Tarsin is capable of providing clients with integration and support for over 700 mobile carriers globally on a seamless and secure platform to take advantage of the increasing demand for rich mobile content.
Consorteum's flagship CAPSA technology platform brings a universal solution to the problems of wagering and betting on mobile devices. Multiple different operating systems, user interfaces, and form factors have created enormous barriers to launching commercial initiatives. But with CAPSA, gaming operators can now cost-effectively monetize innovative mobile wagering products and services quickly and robustly.
In addition to its mobile initiatives, Consorteum is also actively engaged in the financial industry, providing MasterCard solutions as well as loyalty and reward programs. The company has strategically designed its business initiatives to create repetitive transactions on an ongoing basis. Consorteum's goal is to have their customers think of them more as partners, rather than just technology providers, for longer-lasting, more profitable relationships. Disclaimer
Consorteum Holdings, Inc. Company Blog
Consorteum Holdings, Inc. News:
Consorteum Holdings wholly-owned subsidiary Tarsin, a Leader in Secure Mobile Platform Technology, Forges New Frontiers in Mobile Gaming
Consorteum Holdings Completes Acquisition of Tarsin Inc.
Consorteum Holdings, Inc. Announces Lead Spokesman for the First Nations MasterCard Program
TiVUS, Inc. (TIVU)
The QualityStocks Daily Newsletter would like to spotlight TiVUS, Inc. (TIVU). Today, TiVUS, Inc. closed trading at $0.0003, even for the day, on 1,845,000 volume with 7 trades. The stock’s average daily volume over the past 60-day daily average volume is 23,713,554 with a 52-week low/high of $0.0001/$0.06.
TiVUS, Inc. (TIVU) is a cutting edge provider of information, content distribution, media management and secure communications to the hospitality industry. The company's state of the art digital technology platform and Internet Protocol (IP) infrastructure presents hotels with a valuable opportunity to generate new revenue while enhancing guests' experiences by providing content that is more relevant to their unique interests.
The company's integrated platform stands far beyond the competition, offering unparalleled guest services such as messaging, folio review, express check outs, energy management and other personalized services while providing the traditional services of Free to Guest (FTG) programming, Video-On-Demand programming, a highly secured high speed internet service and many other interactive services such as gaming.
By combining TV and the web world through unparalleled IPTV/HDTV service, hotels are able to generate additional income through commercial spots, advertisements of local tourist services, hotel promotions and more. Features of the platform includes remote administration, support for more than twenty languages, easy installation and a comprehensive hotel services menu capable of providing detailed information about the hotel and upcoming activities, billing information, room service, guest messages and wake-up services.
The system's architecture consists of a Network Operating Center (NOC) and local hotel servers connected through a point-to-point broadband network. As each guest accesses the network, the resulting traffic generated undergoes analysis based on various criteria. This includes behavioral, geographical, seasonality, and more. Using this data, hotels are able to ensure advertisers maximum value for their advertising budget. Disclaimer
TiVUS, Inc. Company Blog
TiVUS, Inc. News:
TiVUS' Ad-Insertion Attracts Diverse Range of Advertisers
TiVUS' First Ad-Insertion Revenues Begin - Hotel TV advertising embraced by local merchants
TiVUS Commences Live Hotel TV Ad-Insertions
FluoroPharma Medical, Inc. is a company seeking to develop breakthrough molecular imaging agents for the PET (positron emission tomography) type of 3D medical imaging of the human body to meet critical medical needs.
The company is not involved with the PET machinery, but instead provides the much-needed imaging agents necessary for PET imaging. These agents are designed to improve patient diagnoses and management by evaluating various forms of cardiac disease at the cellular and molecular level.
Each year in the U.S., millions of patients undergo molecular imaging studies to detect and evaluate various forms of coronary artery disease (CAD). These images are helpful to doctors who treat coronary artery disease and, in particular, help doctors diagnose patients with suspected CAD.
This is a very large market. In the United States, there are an estimated 12 million PET imaging procedures done per year. However, the vast majority of these scans are for the diagnosis of cancer. Doctors have traditionally opted for cheaper options such as MRI or CT scans with cardiac patients.
However, that is changing and there is large potential for FluoroPharma as PET scanning becomes more established in the cardiac sector. This market seems to be quickly shifting in favor of increased usage of PET scans for cardiac patients.
FluoroPharma expects to capitalize on this rapidly growing opportunity in this sector. It will do so through the introduction of its novel imaging agents into a market which is forecast to grow by at least 14% annually over the next five years to nearly a $1 billion market for cardiac patients alone.
The company’s focus at the moment is on four separate cardiac molecular imaging agents, two of which are in clinical stage development and are about to enter Phase II clinical trials. The third pharmaceutical candidate is in an early development stage with clinical testing likely to be several years away and the fourth is still in the discovery phase.
The two most-advanced candidates are: CardioPET, which allows assessment of coronary artery disease while patients are at rest; and BFPET, which is a novel cardiovascular blood flow imaging agent that concentrates in healthy myocardial cells and enables improved detection of CAD in cases of multi-vessel disease.
The third candidate is VasoPET, the only PET agent known to selectively target inflamed atheromatous plaque, making it easy for doctors to identify coronary artery plaque. The final candidate – AZPET – includes an approach for directly imaging plague and the compensatory receptor systems in the elderly to help track the progress of treatment of patients with Alzheimer’s disease.
The goal of the company’s cardiac products is to improve overall patient care in several ways. The products are expected to provide significantly greater diagnostic accuracy compared to current methods, thereby reducing the number of unnecessary diagnostic and therapeutic procedures.
The good news for FluoroPharma is that with the exception of one currently marketed branded cardiac PET tracer, which suffers from some well-known problems, the market for such tracers is basically wide open for the company.
Being one of the main players in a soon-to-be billion dollar market makes FluoroPharma Medical a truly exciting long-term investment opportunity.
Today before the opening bell, GlobalWise Investments, Inc. and its wholly owned subsidiary Intellinetics, Inc., a leading-edge technology company focused on the design, implementation and management of cloud-based Enterprise Content Management (“ECM”) systems in both the public and private sectors, provided an overview of the company’s new management team. The diverse roster of highly experienced professionals contribute a combined total of more than 150 years in ECM industry experience.
William J. “BJ” Santiago, President and CEO. BJ has more than 20 years of senior executive-level management experience with an emphasis in sales, operations and M&A activities in the public and private sectors. During his previous tenure at Lexmark, BJ was hand selected in 2008 by the Lexmark CEO to launch and lead all operations for the newly formed Content Management Sales Practices for North America, which was using the Intellinetics platform. Through this business venture, Intellinetics recognized his ability as an ECM industry thought leader. From here, he became a natural catalyst for Intellinetics’ business development and strategy. BJ also served eight years as a United States Army Infantry Officer and is a veteran of Operation Desert Storm.
Matthew Chretien, EVP and Chief Technology Officer. Matthew is a co-founder of Intellinetics and a strategic entrepreneur backed by more than 20 years of experience in technology sales, consulting and software product life cycle management within the aerospace, public safety, government and select commercial markets. After graduating from The Ohio State University with an engineering degree in 1990, he spent two years in the Fisher College of Business Doctoral Program at Ohio State in computer science to work on his Ph.D. During this period, Matthew discovered his research would be far too narrow to satisfy his interests and ultimately co-founded Intellinetics in 1994.
Michael Chretien, VP and Corporate Counsel. Michael is a co-founder of Intellinetics. After graduating from the University of Massachusetts with a Bachelor of Arts in economics in 1961, he joined the United States Marine Corps and retired in 1965 as a 1st Lieutenant. Michael continued to serve his country for 26 years in law enforcement and foreign counter intelligence. After retirement from government service, he continued his career in the law enforcement field by studying for his Juris Doctorate and was awarded a law degree from Capital University Law School in 1991. Michael’s next move was founding Intellinetics with his son Matthew using his law enforcement background as a client resource to consult and assist with document storage and various other IT-related solutions.
Continued at the following link: GlobalWise Investments, Inc. (GWIV) Provides Introduction of Seasoned Management Team
A123 Systems, a leading developer and manufacturer of advanced lithium-ion batteries and energy storage systems for transportation, electric grid, and commercial applications, today introduced its Military 6T Battery, engineered specifically for military vehicle applications.
The new battery system was developed to replace the 6T lead acid batteries currently deployed in military vehicles. A123 says the Military 6T Battery features a longer-lasting, lighter-weight system for engine start and enabling longer-duration silent watch functionality.
“There are nearly 800,000 6T batteries currently deployed in U.S. military vehicles, and in 2010 alone, the military purchased about 300,000 6T batteries. Virtually all of these are lead acid, so we believe this creates a significant opportunity for our lighter-weight, longer-lasting, higher-performance lithium iron phosphate Military 6T Battery,” Les Alexander, general manager for the Government Solutions Group at A123 stated in the press release.
The Military 6T Battery is based on A123′s proprietary Nanophosphate® lithium iron phosphate technology. The Military 6T Battery leverages the systems engineering and manufacturing design utilized to produce A123′s 12V Engine Start Battery, which is currently offered to commercial automakers.
The company’s battery products offer longer life cycle compared to other battery technologies; are capable of rapid charging and powerful delivery; are 50 percent lighter than lead acid battery systems, which improves fuel economy for transport vehicles on the battlefield; and are equipped with battery management electronics to help balance and safeguard the cells.
“Our new solution has successfully demonstrated the ability to start a High-Mobility Multipurpose Wheeled Vehicle (HMMWV), and we have begun delivering 6T systems to a number of defense contractors so they can evaluate its performance as a first step toward potential high-volume production. We believe we can leverage our expertise in developing industry-leading products for commercial markets as well as our vertically integrated manufacturing capabilities to deliver systems that will complement the DoD’s strategy for deploying more energy-efficient technologies,” Alexander stated.
A123 will showcase the Military 6T Battery and its other government and military at the Association of the United States Army (AUSA) Winter Symposium, Feb. 22-24, 2012, in Fort Lauderdale, Fla.
ImmunoCellular Therapeutics, a clinical-stage company developing immune-based therapies for the treatment of brain and other cancers, today announced it has entered into an agreement with the University of Pennsylvania, under which ImmunoCellular is granted exclusive worldwide licensing for a patent pending technology for the production of high-activity dendritic cells (DCs).
ImmunoCellular said the licensed technology underlies its lead DC-based cancer vaccine candidate, ICT-107, for the treatment of glioblastoma multiforme. The license covers the application of the technology toward the development of therapeutics for all indications, excluding cancer and ductal carcinoma in situ.
The agreement enhances the value of ImmunoCellular’s intellectual property related to ICT-107, and as stated by Manish Singh, Ph.D., ImmunoCellular’s president and CEO, positions the company to reduce manufacturing costs associated with the vaccine.
“This licensing agreement represents an expansion of our intellectual property surrounding the technology underlying our lead product candidate, ICT-107. In addition to contributing to the powerful immune responses to ICT-107 we have observed to date, this technology also enables the manufacture of multiple vaccine shots from a single production run, allowing us to significantly reduce the cost of manufacturing the vaccine. As we continue advancing our ongoing phase II trial in glioblastoma, we are confident that will continue to realize the benefits of the enhanced efficacy and efficiency of this innovative dendritic-cell production method,” Dr. Singh stated in the press release.
The technology was developed by Brian J. Czerniecki, M.D., Ph.D., co-director of University of Pennsylvania’s Rena Rowan Breast Cancer Center and surgical director of the immunotherapy program at the Abramson Cancer Center.
Today's Top 3
The QualityStocks Public Company Sponsor News